Generic Medicines Transition Tender
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £7,343,989 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Scotland |
| Deadline | 10 Mar 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-0314bb |
Awards (13)
This procurement was awarded to 13 suppliers. Values shown are per-award; the notice total is £7,343,989.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | · | · | active |
| Aguettant Ltd shared | · | · | active |
| AOP Orphan Ltd shared | · | · | active |
| Bayer Plc shared | · | · | active |
| B.Braun Medical Limited shared | · | · | active |
| Bristol-Myers Squibb Pharmaceuticals shared | · | · | active |
| Dr Reddy's Laboratories (UK) Ltd shared | · | · | active |
| Martindale Pharma shared | · | · | active |
| Napp Pharmaceuticals shared | · | · | active |
| Piramal CC shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| Teva UK Limited shared | · | · | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into 7 individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 8 Feb 2022 | Contract notice (F02) | Earlier regulations | 003616-2022 |
| 9 Feb 2022 | Corrigendum (F14) | Earlier regulations | 003692-2022 |
| 20 May 2022 | Contract award notice (F03) | Earlier regulations | 013534-2022 |
more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines · £52,999,636 · 6 Jan 2026
- Contrast Media Agents · £44,036,295 · 27 Jun 2024
- NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines · £35,467,873 · 7 Mar 2024
- Generic and Biosimilar Cancer Medicines · £59,145,973 · 21 Apr 2023
- NP36722 Fertility Products · £6,490,616 · 18 Jan 2023
- NP41422 Contraceptive Medicines · £7,369,432 · 8 Jul 2022
- NP39722f Lenalidomide · £4,300,000 · 7 Jun 2022
- Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine · £19,205,951 · 3 Feb 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.